39 Days Smarter!! MORNING REPORT T U E S D A Y , A U G U S T 9 TH, 2 0 1 1 CXR: ~Superior segment RLL PNA ~Early LLL Complications of Sickle Cell Disease Quick Note on Pathogenesis of SCD… Single nucleotide substitution in the beta globin gene on chromosome 11 substitution of valine for glutamic acid polymerization of HgS on deoxygenation multiple polymers bundle into rodlike structures that distort RBC into crescent shape vascular occlusion, organ ischemia, end organ damage AR in inheritance Clinical Manifestations Appear during first postnatal year Due to decrease in HbF Inhibits deoxy-HbS polymerization in RBC Severity based on Hb varient: SS (Hb 6-8) S-beta0-thalassemia (Hb 7-9) SC (Hb 10-14) S-beta+-thalassemia (Hb 9-12) Clinical Complications of SCD Young children Bacterial infection Splenic sequestration Stroke Adolescents and adults Pulmonary HTN Renal disease Stroke Avascular necrosis Leg ulcers Chronic pain syndromes 2nd leading cause of admissions after VOC More common in children but more severe in adults Acute Chest Syndrome Acute Chest Syndrome Definition: The radiologic appearance of new pulmonary infiltrate involving at least one complete lung segment plus one of the following Fever >38.5 Hypoxia Chest pain Signs of respiratory distress (tachypnea, wheezing, cough, retractions) Acute Chest Syndrome Triggers: Infection (bacteria, viruses, Mycoplasma, Chlamydia) VOC (fat embolism, hypoventilation) Asthma Treatment: Broad spectrum Abx (cephalosporin + macrolide) Oxygen (Pox>92%) Hydration Incentive Spirometry Early intervention with simple transfusion Exchange transfusion Reserved for patients with progressive, multilobe infiltrates and hypoxia Aplastic Crisis Most common cause of transient red cell aplasia Presentation: Fever URI Sx Fatigue Pallor (with absence of scleral icterus) Decrease in baseline Hb with reticulocytopenia 7-10 days Dx: Parvovirus B19 IgM Tx: Supportive care (transfusion) Osteomyelitis Salmonella*, S. aureus Clinical presentation with significant overlap with VOC No definitive imaging modality can differentiate with certainty Diagnosis on clinical assessment Fever Leukocytosis ESR +BCx Bacteremia/ Sepsis Functional asplenia At 1 yo 30% At 6 yo 90% Risk of S. pneumoniae bacteremia 400-fold higher in SCD Prevention PCN Pneumococcal immunizations Parenteral Abx (ceftriaxone) still standard of care with temp>101 Acute Splenic Sequestration Occurs in children<3 yo with HbSS and at any age with the other HbS varients Clinical Characteristics Sudden enlargement of spleen 2 g/dL drop in HgB from baseline Reticulocytosis +/- Thrombocytopenia Frequently results in circulatory collapse!! Cerebrovascular Disease Significant cause of morbidity in children with SCD Stroke in HbSS patients 11% overt stroke by age 20 Additional 22% with silent strokes 75% ischemic or thrombotic Neuropsychometric defecits learning and cognitive problems Peak incidence 2-10 yo Large artery disease Internal carotid Anterior and middle cerebral arteries Cerebrovascular Disease Prevention TCD Screening recommended in all children between 2-16y Detecting children at risk Flow velocity >200cm/sec Chronic transfusion therapy Goal: HbS <30% Prevents second stroke in 80% Reduces stroke risk 10 fold for patients with at risk TCDs Chronic Organ Damage Pulmonary HTN Renal disease Avascular necrosis Leg ulcers Priapism Cholelithiasis Chronic pain syndromes Thanks for your attention! NOON CONFERENCE: CARDIAC SURGICAL REPAIR, DR. JASON TURNER